03 October 2018: Global General
Anesthesia Drug Market is segmented on the basis of type, routes
of administration, molecule, application and geography. General anesthesia
drugs are used to induce a sedative state in patients who are to go through a
surgical procedure. Further, general an asthesia drugs can be segmented into
two sub-segments based on the route of administration, general anesthesia drugs
administered through the intravenous route is categorized as an intravenous
anesthetic and general anesthesia drugs administered through inhalation is
categorized as an inhalation anesthetic. It is a must to maintain the sedative
stage in the patient during a surgical procedure, usually for this stage,
inhalation an aesthesia are administered to the patients; while for the
induction stage, intravenous general anaesthesia is preferred. Increasing
number of surgeries, development of new sedative & anesthetic drugs, and
reduction in the cost of newly invented drugs and decrease in the recovery time
after surgery are some of the reasons driving the growth of the market.
Browse Detail TOC of
General Anesthesia Drugs Market Research Report at:
https://www.millioninsights.com/industry-reports/general-anesthesia-drug-market
Risk of side effects of anesthesia drugs, lack of skilled anesthetists to administer the drugs and risk of adverse reactions of anesthesia drugs are some of the major constraints hindering the market growth. Growth of the general anesthesia drugs market is mainly driven by rising incidences of cardiovascular diseases, chronic respiratory diseases, craniomaxillofacial surgeries and accidents. However, lack of a single effective drug for all type of surgeries, side effects and complications during the surgical procedure, lack of skilled anesthesiologists and certified registered nurse anesthesiologists, inadequate insurance coverage, coupled with high prices of these drugs are restraining market growth. In addition, side effects such as nausea, vomiting, allergy, sleep apnea and complications during surgical procedures are anticipated to drive the demand for improvement in the quality of drugs.
https://www.millioninsights.com/industry-reports/general-anesthesia-drug-market
Risk of side effects of anesthesia drugs, lack of skilled anesthetists to administer the drugs and risk of adverse reactions of anesthesia drugs are some of the major constraints hindering the market growth. Growth of the general anesthesia drugs market is mainly driven by rising incidences of cardiovascular diseases, chronic respiratory diseases, craniomaxillofacial surgeries and accidents. However, lack of a single effective drug for all type of surgeries, side effects and complications during the surgical procedure, lack of skilled anesthesiologists and certified registered nurse anesthesiologists, inadequate insurance coverage, coupled with high prices of these drugs are restraining market growth. In addition, side effects such as nausea, vomiting, allergy, sleep apnea and complications during surgical procedures are anticipated to drive the demand for improvement in the quality of drugs.
On the basis of type, the general
anesthesia drug market is segmented into spinal anesthesia, general anesthesia,
interscalene block, IV regional anesthesia, local anesthesia, saddle block
anesthesia, peripheral nerve block and so on. These drugs are usually used to
assist surgery. These drugs are used to produce loss of consciousness before
and during surgery. However, for obstetrics (labor and delivery) or certain
minor procedures, an anesthetic may be given in small amounts to relieve
anxiety or pain without causing unconsciousness. Some of the anesthetics may be
used for certain procedures in a medical doctor’s or dentist’s office. On the
basis of routes of administration, the general anesthesia drug market is
segmented into inhalation, intravenous and injection. On the basis of molecule,
the general anesthesia drug market is segmented into propofol, benzodiazepine
(midazolam and diazepam), ketamine (esketamine hydrochloride or S-(+) -
ketamine hydrochloride), methohexital sodium, and so on.
Request Free Sample
Copy of General Anesthesia Drugs Market Research Report at:
https://www.millioninsights.com/industry-reports/general-anesthesia-drug-market/request-sample
https://www.millioninsights.com/industry-reports/general-anesthesia-drug-market/request-sample
On the basis of geography, the
general anesthesia drug industry is segmented into Asia Pacific, North America,
Latin America, Europe and Middle East & Africa. On the basis of
application, the general anesthesia drug industry is segmented into hospital
use and clinic use. North America dominated the market share of the overall
general anaesthesia drugs market in 2015.The key players in general anesthesia
drug industry include AstraZeneca Plc., Fresenius-Kabi, AbbVie Laboratories,
Baxter Healthcare, B.Braun, Maruishi, Piramal Healthcare, Hikma
Pharmaceuticals, Mylan N.V., Eisai Co. Ltd., Fresenius Se & Co. KgaA,
Abbott, Hospira Inc., Novartis, Roche, Nhwa, Hengrui, Boehringer Ingelheim, Par
Pharmaceutical Companies Inc. and Lunan.
No comments:
Post a Comment